Filing Details
- Accession Number:
- 0001209191-23-023336
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-05 16:34:25
- Reporting Period:
- 2023-04-03
- Accepted Time:
- 2023-04-05 16:34:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Biosciences Inc. | PCRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365619 | Laura Brege | C/O Pacira Biosciences, Inc. 5401 West Kennedy Boulevard, Suite 890 Tampa FL 33609 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-03 | 7,000 | $29.90 | 17,147 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-03 | 7,000 | $40.72 | 10,147 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-04-03 | 7,000 | $0.00 | 7,000 | $29.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-06-12 | No | 4 | M | Direct |
Footnotes
- The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- The option vested in 12 equal monthly installments, provided that the reporting person remained in continuous service with the issuer through each vesting date, and became fully exercisable on June 12, 2014.
Billionaire Hedge Funds
